Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans
Other Titles
Abstract
The present study assessed the schistosomicidal and fasciolicidal actions of the myrrh-derivative Mirazid in an area of low schistosomiasis transmission. A total of 27 patients infected with Schistosoma mansoni and 16 with Fasciola spp. received the maximum recommended dose of Mirazid. Pretreatment egg counts in 4 Kato-Katz slides were compared with similar counts in stool samples collected 1 and 2 months after treatment. Standard procedures and quality control measures were followed. The results revealed that Mirazid used as schistosomicidal or fasciolicidal agent in the maximum recommended dose has a low cure rate and produced a negligible reduction in egg counts. Prescribing such an ineffective drug in Egypt might endanger the achievements of the schistosomiasis control strategy
Citation
Osman, M.M., El Taweel, H.A., Shehab, A.Y. & Farag, H.F. (2010). Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans. EMHJ - Eastern Mediterranean Health Journal, 16 (9), 932-936, 2010, https://iris.who.int/handle/10665/117981
Journal
EMHJ - Eastern Mediterranean Health Journal, 16 (9), 932-936, 2010
Relation
Temporal Coverage
Statement of Responsibility
Description
932-936
Table of Contents
Version
Sponsorship
PMID
PMCID
Document number
ISBN
ISSN
1020-3397
ISMN
Identifiers
Other Identifiers
http://applications.emro.who.int/emhj/V16/09/16_9_2010_0932_0936.pdf
Format
Language
English